Ridgeback Capital Investments L.P. 13D and 13G filings for Bicycle Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:08 pm Sale | 2023-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 844,235 2.200% | -1,420,566 (-62.72%) | Filing |
| 2023-02-14 4:06 pm Unchanged | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 2,264,801 7.600% | 0 (Unchanged) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 2,264,801 7.600% | 100,000 (+4.62%) | Filing |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 2,164,801 7.400% | 302,968 (+16.27%) | Filing |
| 2021-02-16 4:17 pm Purchase | 2020-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 1,861,833 8.700% | 717,200 (+62.66%) | Filing |
| 2020-07-13 4:28 pm Purchase | 2020-07-02 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 1,144,633 6.300% | 1,144,633 (New Position) | Filing |